Catherine Gordley focuses on EU competition law.
Her practice includes advising clients in EU and multi-jurisdictional merger proceedings, and in antitrust and abuse of dominance investigations.
She has particular experience in the life sciences sector, including advising pharmaceutical companies on matters related to distribution, pricing, product denigration and generic/biosimilar market entry.
Catherine’s merger control experience spans several sectors, including steel, chemicals, consumer products and basic industries.
Prior to joining Van Bael & Bellis, Catherine worked as a litigation and arbitration associate in the New York office of a leading international law firm.